[Ramadan fasting during treatment with external beam radiotherapy].

L’observance du jeûne de Ramadan pendant le traitement par radiothérapie externe.

Journal

Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 21 05 2019
revised: 04 05 2021
accepted: 18 05 2021
pubmed: 16 11 2021
medline: 18 3 2022
entrez: 15 11 2021
Statut: ppublish

Résumé

Many Muslim cancer patients insist on fasting during the month of Ramadan, even during treatment. The purpose of this observational study is to study the practice of fasting, in patients receiving external radiation therapy. Our study was conducted during the month of Ramadan 1441 (2018) in the radiotherapy department of Ibn Rochd University Hospital of Casablanca. We included all patients who received external radiotherapy during this period. We thus collected the characteristics of patients, disease and treatment modalities. After an interview, with a pre-established questionnaire, we were able to establish the observance of the fast. We collected a total of 209 patients. The most frequently represented locations were breast cancer followed by gynecological cancers in 35.4% and 18.7% respectively. All our patients were fasting Ramadan before the diagnosis of cancer, however, only 39.2% were fasting during the treatment by radiotherapy, and just 40% of patients have discussed the possibility of fasting with their oncologist. In multivariate analysis, the stage of the disease was the only factor related to the fasting status of our patients. Even under treatment, many of our patients fast during the month of Ramadan. Further studies are needed to evaluate the tolerance of fasting in order to better answer the question "can I fast?".

Identifiants

pubmed: 34776116
pii: S0007-4551(21)00304-0
doi: 10.1016/j.bulcan.2021.05.010
pii:
doi:

Types de publication

Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

331-337

Informations de copyright

Copyright © 2021 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Amine Lachgar (A)

CHU Ibn Rochd, service de radiothérapie, Casablanca, Maroc. Electronic address: lachgar.amine@gmail.com.

Sara Ridai (S)

CHU Ibn Rochd, service de radiothérapie, Casablanca, Maroc.

Safaa Mouafik (S)

CHU Ibn Rochd, service de radiothérapie, Casablanca, Maroc.

Hajar Kaiss (H)

CHU Ibn Rochd, service de radiothérapie, Casablanca, Maroc.

Nadir Sahli (N)

CHU Ibn sina Rabat, Institute national d'oncologie, service de radiothérapie, Rabat, Maroc.

Hassan Jouhadi (H)

CHU Ibn Rochd, service de radiothérapie, Casablanca, Maroc.

Abdelatif Benider (A)

CHU Ibn Rochd, service de radiothérapie, Casablanca, Maroc.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH